BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37095178)

  • 21. Detecting EGFR mutations and ALK/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples.
    Yao Y; Peng M; Shen Q; Hu Q; Gong H; Li Q; Zheng Z; Xu B; Li Y; Dong Y
    Thorac Cancer; 2019 Feb; 10(2):193-202. PubMed ID: 30565433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of pleural effusion Krebs von den Lungen-6 in malignant pleural effusion of patients with non-small cell lung cancer.
    Wang J; Ling L; Chen S; Chou L; Wang Y; Hu L
    Lab Med; 2024 May; 55(3):271-276. PubMed ID: 37566516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-cell transcriptomics reveal metastatic CLDN4+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non-small-cell lung cancer.
    Zhang X; Wang X; Wen Y; Chen S; Zhou C; Wu F
    Clin Transl Med; 2024 Apr; 14(4):e1649. PubMed ID: 38629624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Label-Free Quantitative Proteomics Identifies Novel Biomarkers for Distinguishing Tuberculosis Pleural Effusion from Malignant Pleural Effusion.
    Pan L; Zhang X; Jia H; Huang M; Liu F; Wang J; Du B; Wei R; Sun Q; Xing A; Li Q; Zhang Z
    Proteomics Clin Appl; 2020 Jan; 14(1):e1900001. PubMed ID: 31715074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion.
    Bao Q; Xu Y; Ding M; Chen P
    Hereditas; 2020 Feb; 157(1):6. PubMed ID: 32102688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion.
    Zhang H; Li C; Hu F; Zhang X; Shen Y; Chen Y; Li F
    Respir Res; 2020 Oct; 21(1):284. PubMed ID: 33121490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a machine learning model for differential diagnosis of malignant pleural effusion using routine laboratory data.
    Wei TT; Zhang JF; Cheng Z; Jiang L; Li JY; Zhou L
    Ther Adv Respir Dis; 2023; 17():17534666231208632. PubMed ID: 37941347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
    Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
    Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant pleural effusion cell blocks are substitutes for tissue in EML4-ALK rearrangement detection in patients with advanced non-small-cell lung cancer.
    Zhong J; Li X; Bai H; Zhao J; Wang Z; Duan J; An T; Wu M; Wang Y; Wang S; Wang J
    Cytopathology; 2016 Dec; 27(6):433-443. PubMed ID: 27060609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.
    Zhu J; Feng M; Liang L; Zeng N; Wan C; Yang T; Shen Y; Wen F
    BMC Cancer; 2017 Aug; 17(1):590. PubMed ID: 28854885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
    Dong J; Sun G; Zhu H
    Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study.
    Choi H; Ko Y; Lee CY
    BMC Cancer; 2020 Aug; 20(1):825. PubMed ID: 32867726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer.
    Biaoxue R; Min L; Tian F; Wenlong G; Hua L
    BMC Pulm Med; 2018 Dec; 18(1):188. PubMed ID: 30522463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pleural fluid carbohydrate antigen 72-4 and malignant pleural effusion: a diagnostic test accuracy study.
    Cao XS; Yan L; Jiang TW; Huang JH; Chen H; Porcel JM; Zheng WQ; Hu ZD
    Ther Adv Respir Dis; 2024; 18():17534666231222333. PubMed ID: 38189269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory Discrimination Between Neutrophilic Malignant and Parapneumonic Pleural Effusions.
    Lee J; Lee YH; Seo H; Lee H; Kim YK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
    Am J Med Sci; 2019 Aug; 358(2):115-120. PubMed ID: 31331448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell block samples from malignant pleural effusion might be valid alternative samples for anaplastic lymphoma kinase detection in patients with advanced non-small-cell lung cancer.
    Zhou J; Yao H; Zhao J; Zhang S; You Q; Sun K; Zou Y; Zhou C; Zhou J
    Histopathology; 2015 Jun; 66(7):949-54. PubMed ID: 25257756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of human epididymis secretory protein 4 in differentiating malignant from benign pleural effusion: an analysis of two cohorts.
    Yang Q; Niu Y; Wen JX; Yang DN; Han YL; Wen XH; Yan L; Huang JH; Chen H; Zheng WQ; Jiang TW; Hu ZD
    Ther Adv Respir Dis; 2023; 17():17534666231216566. PubMed ID: 38084849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples.
    Zou Y; Xu L; Tang Q; You Q; Wang X; Ding W; Zhao J; Ren G
    BMC Cancer; 2020 Apr; 20(1):344. PubMed ID: 32321471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytological-negative pleural effusion can be an alternative liquid biopsy media for detection of EGFR mutation in NSCLC patients.
    Song Z; Wang W; Li M; Liu J; Zhang Y
    Lung Cancer; 2019 Oct; 136():23-29. PubMed ID: 31421258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical value of combined detection of reactive oxygen species modulator 1 and adenosine deaminase in pleural effusion in the identification of NSCLC associated malignant pleural effusion.
    Zhang F; Wang J; Fu J; Hu L; Zheng X; Wang Y; Chen B
    J Clin Lab Anal; 2020 Mar; 34(3):e23091. PubMed ID: 31709646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.